CONTACT US
CONTACT US
South Africa COVID-19 Prevention Network
  • HOME
  • What To Expect
  • Clinical Studies
  • FAQ’s
  • About Us
  • HOME
  • What To Expect
  • Clinical Studies
  • FAQ’s
  • About Us
  • HOME
  • What To Expect
  • Clinical Studies
  • FAQ’s
  • About Us

About Us

About the COVID-19 Prevention Network (CoVPN)

The COVID-19 Prevention Network (CoVPN) was formed by the National Institute of Allergy and Infectious Diseases (NIAID) at the US National Institutes of Health to respond to the global pandemic. Using the infectious disease expertise of their existing research networks and global partners, NIAID has directed the networks to address the pressing need for vaccines and monoclonal antibodies (mAbs) against SARS-CoV-2. The CoVPN is comprised of the partners listed below.

Our Mission

To conduct Phase 3 efficacy trials for COVID-19 vaccines and monoclonal antibodies. The CoVPN will work to develop and conduct studies to ensure rapid and thorough evaluation of US government-sponsored COVID-19 vaccines and monoclonal antibodies for the prevention of COVID-19 disease.

Partners

The HIV Vaccine Trials Network (HVTN) is the world’s largest publicly funded international collaboration focused on the development of vaccines to prevent HIV/AIDS.

The HIV Prevention Trials Network (HPTN) develops and tests the safety and efficacy of non-vaccine interventions designed to prevent the transmission of HIV.

NIAID established the Infectious Diseases Clinical Research Consortium in 2019. It encompasses the Institute’s long-standing Vaccine and Treatment Evaluation Units (VTEUs) and a new leadership group.

The ACTG established and supports the largest Network of expert clinical and translational investigators and therapeutic clinical trials units in the world. These investigators and units serve as the major resource for HIV/AIDS research on treatment and care for persons living with HIV/AIDS.

If you have questions about the studies, please check the Frequently Asked Questions.

We have clinics all over South Africa, and sites will continue to be added as needed for each study. Different clinics will be running each of the different studies that are coming up in the next several months. Interested in volunteering for a COVID-19 Prevention Clinical Trial? Select the button below for more information about the COVID-19 Clinical Trial and how you can become a volunteer. The COVID-19 Prevention Network does not provide personal medical advice or diagnoses. If you are experiencing a medical emergency, call 911 and notify the operator if you think you might have COVID-19. If you think you have been exposed to COVID-19 and develop a fever and symptoms such as a cough or difficulty breathing, call your healthcare provider immediately for medical advice.

Funding Acknowledgement

This Network is funded by the National Institute of Allergy and Infectious Diseases, National Institutes of Health.

CoVPN Operations Centers


c/o CoVPN / HVTN

Hutchinson Center for Research Institute South Africa

New Nurses Home Building, Floor 10

Chris Hani Baragwanath Hospital

Soweto, Johannesburg

South Africa

Thank you for helping us end the uncertainty!

Our current enrollment is closed for now, but we'll have new upcoming studies in 2021

Thank you for helping us end the uncertainty!

Our current enrollment is closed for now, but we'll have new upcoming studies in 2021

Connect with Us

Website Policies & Notices

  • Privacy Policies
  • Disclaimers